SAN DIEGO, Oct. 10, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis
Dixie Botanicals Canada® will be introducing its line of cannabidiol (CBD)-only, consumer-friendly products to the recently legalized Canadian cannabis market. All Dixie Botanicals Canada® products are crafted using expertly cultivated and scientifically-extracted cannabis oil and will be available in a variety of delivery methods including liquids, capsules, and oral sprays.
"The company is pleased to be launching this well-known and highly-regarded brand to such a promising market," said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. "Dixie Botanicals Canada now offers a collection of innovative, high-quality products while consistently meeting their ever-growing customers' needs."
The launch of Dixie Botanicals in Canada follows Medical Marijuana, Inc.'s recent announcement of its signed contract with Salvation. Through its new agreement with Salvation, Medical Marijuana, Inc. will continue to offer the same level of quality and expertise with many of these prestigious brands and products in Canada.
"Medical Marijuana, Inc. will continue to be a company of firsts by being one of the first companies to work with one of Canada's premium manufacturers to bring innovative products to market," said Medical Marijuana, Inc. Director of Canadian Operations, Kenneth Smith. "We are excited the see the many opportunities this new market brings and the many people who we're able to help get access to CBD through this new brand."
"Salvation is very pleased to be working with the Medical Marijuana, Inc. team," said Salvation Chief Finance Officer Rob McIntyre. "They bring a wealth of knowledge that will assist Salvation in providing the Canadian market with the highest quality products possible."
Medical Marijuana, Inc. produces industry-leading CBD brands including Dixie Botanicals®, Real Scientific Hemp Oil™ (RSHO™), Cannabis Beauty Defined®, HempMeds® and Phyto Animal Health™ in the United States and many other Latin American and European countries for distribution.
About Dixie Botanicals Canada®
Regarded as one of the most well-recognized brands in the industry, Dixie Botanicals® Canada offers innovative cannabidiol (CBD) products for health-conscious consumers. Our formulation experts include scientists, clinical herbalists and nutritionists who work to integrate our cannabis oil into a variety of unique products. We test and analyze our products from seed to shelf, ensuring that every natural product we offer is free from contaminants and of the highest quality possible. For more information, visit: https://dixiebotanicals.ca.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
About Salvation Botanicals, Ltd.
Salvation Botanicals is a private company based in Vancouver Island, British Columbia, that is dedicated to the testing and production of high quality standardized cannabinoid products for the international cannabis market. Salvation operates one of the first analytics laboratories in Canada, licensed by Health Canada to test cannabis and derivatives.
Salvation Botanicals holds a Dealer's License under the Controlled Substances Act, with authority to extract and produce oil within Health Canada guidelines. In 2016 Health Canada granted Salvation a Hemp Processing License (HPL) permitting production and sale and export of seed & grain and its derivatives.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: the terms and conditions of the proposed transaction; the terms and conditions of the proposed private placement; use of funds; and the business and operations of the Company after the proposed change of business. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the cannabis industry in North America. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Salvation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT:Public Relations Contact:Andrew HardChief Executive Officer CMW MediaP. email@example.com
View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-launches-dixie-botanicals-canada-300728451.html
SOURCE Medical Marijuana, Inc.
Subscribe to our Free Newsletters!
Fennel seeds are a must-have in almost every Indian kitchen due to its health quotient. Here are a ...
True vertigo is a severe form of dizziness that is a movement hallucination. Try out some of these ...
Oxidative stress is a form of injury to body tissues due to increase in free radicals. If the ...View All